Efficacy of enhanced recovery protocols implementation in cardiac surgery. Randomized clinical trial - ERACSE

Hermanos Ameijeiras Hospital0 个研究点目标入组 84 人开始时间: 2019年11月20日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

研究类型: Interventional
分配方式: Randomized controlled trial. Masking: Double Blind. Control group: Active. Assignment: Parallel. Purpose: Prevention

•1. Obtain Informed consent
•2. Patient without prior cardiac surgery.
•3. Functional classification by NYHA or Canadian society in grade I, II or III.
•4. Cardiac ejection fraction more than 45 %.
•5. Absent of symptomatic arrhythmias.
•6. Alert and without neurological dysfunction.
•7. Urinary output more than 0.5 ml/Kg body weight, with creatinin level less than 132 mmol/l.
•8 Absent of lung congestion sing in the thoracic X-ray.

•1. Urgent or emergent cardiac surgery.
•2. Acute myocardial infarction (less than 7 days) or recently (between 7 and 30 days).
•3. Third degree of atrial - ventricle blockade.
•4. Sing of Cardiac failure.
•5. Preoperative use of inotropic drugs or mechanical support.
•6. Obstructive lung diseases.
•7. Patients with Coagulations disorders.
•8. Patients with diagnosis of any diseases resulting in decrease of gastric empty, as Diabetes, peptic ulcer, pylorus stenosis or gastric tumor.

发起方